Rapt Therapeutics logo

Rapt Therapeutics share price today

(RAPT)

Rapt Therapeutics share price is $1.72 & ₹147.59 as on 7 Jan 2025, 2.30 'hrs' IST

$1.72

0.05

(2.99%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Rapt Therapeutics share price in Dollar and Rupees. Guide to invest in Rapt Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rapt Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Rapt Therapeutics share price movements

  • Today's Low: $1.60
    Today's High: $1.72

    Day's Volatility :6.98%

  • 52 Weeks Low: $0.79
    52 Weeks High: $27.35

    52 Weeks Volatility :97.11%

Rapt Therapeutics Returns

PeriodRapt Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-11.17%
-8.4%
0.0%
6 Months
-48.14%
-3.8%
0.0%
1 Year
-93.13%
-0.1%
0.0%
3 Years
-94.92%
2.9%
-19.8%

Rapt Therapeutics Key Statistics

in dollars & INR

Previous Close
$1.67
Open
$1.67
Today's High
$1.72
Today's Low
$1.6
Market Capitalization
$55.2M
Today's Volume
$1.1M
52 Week High
$27.35
52 Week Low
$0.78925
Revenue TTM
$0.0
EBITDA
$-113.6M
Earnings Per Share (EPS)
$-2.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-80.13%

How to invest in Rapt Therapeutics from India?

It is very easy for Indian residents to invest directly in Rapt Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rapt Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rapt Therapeutics or RAPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rapt Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rapt Therapeutics shares which would translate to 0.499 fractional shares of Rapt Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rapt Therapeutics, in just a few clicks!

Returns in Rapt Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rapt Therapeutics investment value today

Current value as on today

₹10,295

Returns

₹89,705

(-89.71%)

Returns from Rapt Therapeutics Stock

₹92,928 (-92.93%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Rapt Therapeutics

36.9%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Investment in Rapt Therapeutics from India has grown in the last 30 days as on Jan 7, 2025. 36.9% more purchase transactions for Rapt Therapeutics in the last 30 days versus the previous period.

143%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Rapt Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 143% more investors are searching Rapt Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Rapt Therapeutics

  • FMR Inc

    14.98%

  • Vanguard Group Inc

    9.03%

  • Column Group LLC

    7.67%

  • BlackRock Inc

    6.98%

  • Kingdon Capital Management LLC

    4.93%

  • D. E. Shaw & Co LP

    3.00%

Analyst Recommendation on Rapt Therapeutics

Buy

    64%Buy

    35%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Rapt Therapeutics(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
16
Hold
6
6
1
Sell
0
0
0

Analyst Forecast on Rapt Therapeutics

What analysts predicted

Upside of 248.84%

Current:

$1.72

Target:

$6.00

Insights on Rapt Therapeutics

  • Price Movement

    In the last 1 month, RAPT stock has moved up by 58.3%
  • RAPT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 116.6%
  • RAPT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 151.0%

Rapt Therapeutics Technicals Summary

Sell

Neutral

Buy

Rapt Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Rapt Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rapt Therapeutics Inc
42.74%
-48.14%
-93.13%
-94.92%
-93.97%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rapt Therapeutics Inc
NA
NA
NA
-1.68
-0.8
-0.47
NA
2.74
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rapt Therapeutics Inc
Buy
$55.2M
-93.97%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Rapt Therapeutics

rapt therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. rapt has discovered and advanced two unique drug candidates, flx475 and rpt193, each targeting c-c motif chemokine receptor 4 (ccr4), for the treatment of cancer and inflammation, respectively. the company is also pursuing a range of targets that are in the discovery stage of development.
Organization
Rapt Therapeutics
Employees
70
CEO
Dr. Brian Russell Wong M.D., Ph.D.
Industry
Health Technology

Management People of Rapt Therapeutics

NameTitle
Dr. Brian Russell Wong M.D., Ph.D.
CEO, President & Director
Mr. Rodney K. B. Young
CFO, Principal Accounting Officer & Secretary
Dr. William Ho M.D., Ph.D.
Chief Medical Officer
Steve Young Ph.D.
Vice President of Technology
Dr. Dirk G. Brockstedt Ph.D.
Chief Scientific Officer
Mr. Michael Listgarten
General Counsel
Ms. Gwen R. Carscadden
Chief Human Resources Officer
Dr. Paul Kassner
Senior Vice President of Quantitative & Computational Biology
Dr. David Wustrow
Senior Vice President of Drug Discovery & Preclinical Development
Ms. Jennifer Nicholson
Senior Vice President of Regulatory Affairs & Quality Assurance

Important FAQs about investing in Rapt Therapeutics from India :

What is Rapt Therapeutics share price today?

Rapt Therapeutics share price today stands at $1.72, Open: $1.67 ; Previous Close: $1.67 ; High: $1.72 ; Low: $1.60 ; 52 Week High: $27.35 ; 52 Week Low: $0.79. The stock opens at $1.67, after a previous close of $1.67. The stock reached a daily high of $1.72 and a low of $1.60, with a 52-week high of $27.35 and a 52-week low of $0.79.

Can Indians buy Rapt Therapeutics shares?

Yes, Indians can invest in the Rapt Therapeutics (RAPT) from India.

With INDmoney, you can buy Rapt Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rapt Therapeutics at zero transaction cost.

How can I buy Rapt Therapeutics shares from India?

It is very easy to buy Rapt Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rapt Therapeutics be purchased?

Yes, you can buy fractional shares of Rapt Therapeutics with INDmoney app.

What are the documents required to start investing in Rapt Therapeutics stocks?

To start investing in Rapt Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rapt Therapeutics

Today’s highest price of Rapt Therapeutics (RAPT) is $1.72.

Today’s lowest price of Rapt Therapeutics (RAPT) is $1.60.

What is today's market capitalisation of Rapt Therapeutics

Today's market capitalisation of Rapt Therapeutics RAPT is 55.2M

What is the 52 Week High and Low Range of Rapt Therapeutics

  • 52 Week High

    $27.35

  • 52 Week Low

    $0.79

What are the historical returns of Rapt Therapeutics?

  • 1 Month Returns

    42.74%

  • 3 Months Returns

    -48.14%

  • 1 Year Returns

    -93.13%

  • 5 Years Returns

    -93.97%

Who is the Chief Executive Officer (CEO) of Rapt Therapeutics

Dr. Brian Russell Wong M.D., Ph.D. is the current Chief Executive Officer (CEO) of Rapt Therapeutics.